What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?

United Kingdom News News

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?
United Kingdom Latest News,United Kingdom Headlines
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 70 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 71%

What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination? biorxivpreprint mcgillu UofT universitelaval vaccine vaccination COVID19 coronavirus covid

By Bhavana KunkalikarMar 28 2023Reviewed by Danielle Ellis, B.Sc. *Important notice: bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Nevertheless, while certain COVID-19 vaccines are in their phase I/II clinical trials, the effectiveness of this strategy has proven elusive to date. However, the consequences of earlier vaccines and infections are yet to be considered in these models. The effectiveness of a prime-boost immunization schedule with BCG was also studied. Female C57BL/6 mice were inoculated intraperitoneally with 106 colony-forming units of the BCG strain harboring an empty plasmid ) one month before i.n. immunization with Ad. In place of BCG and Ad, PBS was administered to the naive controls.

Results Antibodies eBook Compilation of the top interviews, articles, and news in the last year. Download a free copy Two months following vaccination, Ad-immunized mice demonstrated a substantial reduction in generating infectious SARS-CoV-2 in oral samples. However, when challenged with SARS-CoV-2 six months after vaccination, virus titers noted in vaccinated subjects were similar to those in unvaccinated mice.

The team also discovered that by six months after vaccination, while one Ad dose was effective in lowering viral burden in comparison to controls, this decrease did not have statistical significance. While Ad retained some protective impact after six months, one BCG dose before Ad vaccination enhanced its capacity to monitor viral replication in the respiratory tract.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Global population could fall to six billion with 'unprecedented investment' in tackling poverty, researchers sayGlobal population could fall to six billion with 'unprecedented investment' in tackling poverty, researchers sayThe forecasts in the report are in contrast to UN predictions which show the population reaching 9.7 billion in 2050 and peaking at 10.4 billion in the 2080s.
Read more »

COVID-19 infant hospitalizations reduced by a 3rd maternal vaccine dose during pregnancyCOVID-19 infant hospitalizations reduced by a 3rd maternal vaccine dose during pregnancyResearchers investigated the effects of the booster coronavirus disease 2019 (COVID-19) vaccine during pregnancy on COVID-19-related hospitalization rates among infants.
Read more »

Advancements in understanding and treating breast cancerAdvancements in understanding and treating breast cancerAdvancements in understanding and treating breast cancer BreastCancer Cancer Research Oncology AucklandUni WEHI_research UniMelb
Read more »

Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition? JAMAInternalMed WUSTLmed STLOUISVA SARSCoV2 covid COVID19 coronavirus longcovid disease infection immunology
Read more »

SARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine eraSARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine eraSARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine era PLOSONE theNCI SARSCoV2 reinfection infection covid coronavirus COVID19 vaccine
Read more »

Possible pathways of C. auris emergence and the hypothetical role of interspecies transmissionPossible pathways of C. auris emergence and the hypothetical role of interspecies transmissionPossible pathways of C. auris emergence and the hypothetical role of interspecies transmission HospitalLaFe IISLaFe infection fungi disease health
Read more »



Render Time: 2025-02-24 11:13:13